Redmile Group, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Electra Therapeutics, Inc. 13G 284825106		284825106	8.7%	5,462,881	13G	9/28/2026 Event 9/21/2026
Redmile Group, LLC			8.7%	5,462,881
Jeremy C. Green			8.7%	5,462,881
Redmile Biopharma Investments II, L.P.			7.6%	4,796,215
Nurix Therapeutics, Inc. 13G/A NRIX · 67080M103	NRIX	67080M103	8.1% Checked 5% or less	8,782,256	13G/A	8/14/2026 Event 6/30/2026
Redmile Group, LLC			8.1%	8,782,256
Jeremy C. Green			8.1%	8,782,256
RedCo II Offshore SPV LLC			3.5%	3,712,546
Neurogene Inc. 13G/A NGNE · 64135M105	NGNE	64135M105	9.9%	1,572,202	13G/A	8/14/2026 Event 6/30/2026
Redmile Group, LLC			9.9%	1,572,202
Jeremy C. Green			9.9%	1,572,202
Redmile Biopharma Investments I, L.P.			5.1%	812,033
Scholar Rock Holding Corporation 13G/A SRRK · 80706P103	SRRK	80706P103	3.6%	4,311,092	13G/A	8/14/2026 Event 6/30/2026
Redmile Group, LLC			3.6%	4,311,092
Jeremy C. Green			3.6%	4,311,092
RedCo II Master Fund, L.P.			0%	0
Atara Biotherapeutics, Inc. 13D/A ATRA · 046513206	ATRA	046513206	9.9%	950,994	13D/A	7/24/2026 Event 7/22/2026
Redmile Group, LLC			9.9%	950,994
Green Jeremy			9.9%	950,994
Redmile Biopharma Investments II, L.P.			6.6%	631,020
Redmile Strategic Long Only Trading Sub, Ltd.			4.2%	401,901
Shattuck Labs, Inc. 13D/A STTK · 82024L103	STTK	82024L103	9.9%	10,019,421	13D/A	7/17/2026 Event 7/15/2026
Redmile Group, LLC			9.9%	10,019,421
Jeremy C. Green			9.9%	10,019,421
Redmile Biopharma Investments II, L.P.			8.1%	8,125,342
Annexon, Inc. 13G/A ANNX · 03589W102	ANNX	03589W102	9.9%	17,918,459	13G/A	7/8/2026 Event 7/1/2026
Redmile Group, LLC			9.9%	17,918,459
Jeremy C. Green			9.9%	17,918,459
RedCo II Offshore SPV LLC			5.5%	9,802,458
AgomAb Therapeutics NV 13G AGMB · 00860C102	AGMB	00860C102	5.6%	2,735,926	13G	5/15/2026 Event 3/31/2026
Redmile Group, LLC			5.6%	2,735,926
Jeremy C. Green			5.6%	2,735,926
Redmile Biopharma Investments III, L.P.			5.6%	2,735,926
Stoke Therapeutics, Inc. 13G/A STOK · 86150R107	STOK	86150R107	6.7%	4,164,120	13G/A	5/15/2026 Event 3/31/2026
Redmile Group, LLC			6.7%	4,164,120
Jeremy C. Green			6.7%	4,164,120
Redmile Biopharma Investments III, L.P.			5.6%	3,505,612
Immunome, Inc. 13G/A IMNM · 45257U108	IMNM	45257U108	4.9%	5,558,885	13G/A	5/15/2026 Event 3/31/2026
Redmile Group, LLC			4.9%	5,558,885
Jeremy C. Green			4.9%	5,558,885
ALX Oncology Holdings Inc. 13G/A ALXO · 00166B105	ALXO	00166B105	6.8% Checked 5% or less	9,214,188	13G/A	5/15/2026 Event 3/31/2026
Redmile Group, LLC			6.8%	9,214,188
Jeremy C. Green			6.8%	9,214,188
Redmile Biopharma Investments III, L.P.			3.9%	5,267,838
ADC Therapeutics SA 13G/A ADCT · H0036K147	ADCT	H0036K147	9.9% Checked 5% or less	12,717,487	13G/A	4/24/2026 Event 4/20/2026
Redmile Group, LLC			9.9%	12,717,487
Jeremy C. Green			9.9%	12,717,487
RedCo II Offshore SPV LLC			6.1%	7,780,431
RedCo II Master Fund, L.P.			0%	0
Fate Therapeutics Inc 13D/A FATE · 31189P102	FATE	31189P102	14.9%	18,229,078	13D/A	4/22/2026 Event 4/20/2026
Redmile Group, LLC			14.9%	18,229,078
Jeremy C. Green			14.9%	18,229,078
RedCo II Offshore SPV LLC			8.5%	10,144,307
RedCo II Master Fund, L.P.			0%	0
Absci Corporation 13D/A ABSI · 00091E109	ABSI	00091E109	4.9%	7,607,449	13D/A	4/14/2026 Event 4/10/2026
Redmile Group, LLC			4.9%	7,607,449
Jeremy C. Green			4.9%	7,607,449
Zymeworks Inc. 13G/A ZYME · 98985Y108	ZYME	98985Y108	4.9%	3,705,750	13G/A	11/14/2025 Event 9/30/2025
Redmile Group, LLC			4.9%	3,705,750
Jeremy C. Green			4.9%	3,705,750
Replimune Group, Inc. 13G/A REPL · 76029N106	REPL	76029N106	0.7%	535,818	13G/A	11/14/2025 Event 9/30/2025
Redmile Group, LLC			0.7%	535,818
Jeremy C. Green			0.7%	535,818
IGM Biosciences, Inc. 13D/A IGMS · 449585108	IGMS	449585108	0%	0	13D/A	8/15/2025 Event 8/14/2025
Redmile Group, LLC			0%	0
Jeremy C. Green			0%	0
REGENXBIO Inc. 13G/A RGNX · 75901B107	RGNX	75901B107	9.9%	5,062,477	13G/A	8/14/2025 Event 6/30/2025
Redmile Group, LLC			9.9%	5,062,477
Jeremy C. Green			9.9%	5,062,477
Redmile Biopharma Investments III, L.P.			7.4%	3,733,796
RAPT Therapeutics, Inc. 13G/A RAPT · 75382E208	RAPT	75382E208	9.9%	1,765,303	13G/A	8/14/2025 Event 6/30/2025
Redmile Group, LLC			9.9%	1,765,303
Jeremy C. Green			9.9%	1,765,303
Redmile Biopharma Investments III, L.P.			6.5%	1,147,390
Silence Therapeutics plc 13G/A G8128Y157		G8128Y157	4.7%	6,644,841	13G/A	5/15/2025 Event 3/31/2025
Redmile Group, LLC			4.7%	6,644,841
Jeremy C. Green			4.7%	6,644,841
RAPT Therapeutics, Inc. 13G/A RAPT · 75382E109	RAPT	75382E109	9.9%	13,932,449	13G/A	2/14/2025 Event 12/31/2024
Redmile Group, LLC			9.9%	13,932,449
Jeremy C. Green			9.9%	13,932,449
Redmile Biopharma Investments III, L.P.			5.4%	7,559,323
Pliant Therapeutics, Inc. 13G/A PLRX · 729139105	PLRX	729139105	4.8%	2,895,478	13G/A	2/14/2025 Event 12/31/2024
Redmile Group, LLC			4.8%	2,895,478
Jeremy C. Green			4.8%	2,895,478
Gritstone bio, Inc. 13G/A GRTSQ · 39868T105	GRTSQ	39868T105	8.2% Checked 5% or less	13,163,457	13G/A	2/14/2025 Event 12/31/2024
Redmile Group, LLC			8.2%	13,163,457
Jeremy C. Green			8.2%	13,163,457
RedCo II Master Fund, L.P.			4.7%	7,232,956
Amicus Therapeutics, Inc. 13G/A FOLD · 03152W109	FOLD	03152W109	4.6%	14,184,495	13G/A	2/14/2025 Event 12/31/2024
Redmile Group, LLC			4.6%	14,184,495
Jeremy C. Green			4.6%	14,184,495